Download RGUHS Pharm-D 5th Semester 2011 Feb 2875 Pharmacoepidemiology And Pharmacoeconomics Question Paper

Download RGUHS (Rajiv Gandhi University of Health Sciences) Pharm.D (Doctor of Pharmacy) 5th Semester 2011 Feb 2875 Pharmacoepidemiology And Pharmacoeconomics Question Paper.

2875_2011_1_S184.doc
Rajiv Gandhi University of Health Sciences, Karnataka
Fifth Year Pharma- D Degree Examination ? Feb/March 2011

Time: Three Hours Max. Marks: 70 Marks

PHARMACOEPIDEMIOLOGY AND PHARMACOECONOMICS

Q.P. CODE: 2875

Your answers should be specific to the questions asked
Draw neat labeled diagrams wherever necessary

LONG ESSAYS (Answer any two) 2 x 10 = 20 Marks
1.
Explain and mention the merits and demerits of cohort and case-controlled studies.
2.
What is cost effectiveness analysis? Explain with a suitable example how the outcome is
measure using cost effectiveness analysis.
3
Explain the criteria for the causal nature of an association in pharmacoepidemological
study.

SHORT ESSAYS (Answer any six) 6 x 5 = 30 Marks
4.
Explain the steps involved in typical DUE cycle.
5.
Give the strengths and weakness of a metaanalysis study
6.
List out the applications of a pharnaciecinimic study.
7.
How is confidence interval measured for an odds ratio? How is confidence interval depicted
and graphically interpreted.
8.
Describe the steps involved in formulating a study design in pharmacoepidemiology.
9.
Explain the factors to the determined in a cost of illness study.
10.
Explain the method, advantages and disadvantages of a cross-sectional study.
11.
What are the requirements of an ideal database. Write the strengths and weakness of
automated database

SHORT ANSWERS 10 x 2 = 20 Marks
12.
Name four computerized databases used for pharmacoepidemiological research
13.
What is a case report? What are its limitations.
14.
What is opportunity cost.
15.
What is ICER. How is it calculated
16.
What is willingness to pay
17.
What is outcome research
18.
List out the purpose of meta-analysis
19.
Give examples of intangible costs involved in pharmacoeconomic study
20.
What are defined daily dose and prescribed daily dose?
21.
Explain selection bias

*****


FirstRanker.com - FirstRanker's Choice

This post was last modified on 20 December 2019